Shoshana Shendelman - 25 Jan 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Shoshana Shendelman
Issuer symbol
APLT
Transactions as of
25 Jan 2022
Net transactions value
$0
Form type
4
Filing time
27 Jan 2022, 17:32:51 UTC
Previous filing
11 Jan 2022
Next filing
04 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLT Employee Stock Option (Right to Buy) Award $0 +234,616 $0.000000 234,616 25 Jan 2022 Common Stock 234,616 $3.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. The issuer determined to make this compensatory grant of Options to the Reporting Person in lieu of a cash bonus that otherwise would have been paid with respect to 2021. All of the shares subject to the compensatory Option vested immediately upon grant.